🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Please spread in your networks Prof Kamlesh Khunti Diabetes UK British Heart Foundation Ponnusamy Saravanan Sarah Ali FRSA 👩🏻‍⚕️👩🏻‍🎨 Muhammad Ali Karamat Prof Amitava Banerjee💙 Dr Amar Puttanna 🎸 Amelia Cook Diabetes Nurse specialist ABCD Diabetes Abd Tahrani Punith Kempegowda Dr. Umar ( Umar Diabetes Foundation ) Dr. Shashank Joshi Sheena Bhageerutty ANutr Shailesh V. Shrikhande Dr. Purvi Chawla Banshi Saboo barkha dutt Rajdeep Sardesai

Potential downsides of calorie restriction nature.com/articles/s4157…

GRADE Trial Weight gain associated with worse glycaemic control & increased risk of cardiovascular and kidney outcomes independent of treatment. diabetesjournals.org/care/article/d…

📢 Can LFTs track liver fat loss after weight loss in #T2D? Yes. 🔹 DiRECT sub-study: 74% achieved MASLD remission with ~12kg weight loss 🔸 ⤵️ ALT & GGT = strong predictors of liver fat ⤵️ (ALT >40 = PPV 100%) 🔹 ALT change most closely linked to liver fat ⤵️ 🔸 LFTs =

Living with #Diabetes? Want to know how to prepare for your next dental appointment? 🦷🪥📆 Check out our dental guide for #PwD at the Perio-Diabetes Hub Hub. Made with care. Backed by expertise. Shaped by lived experience. periodiabetes.org/wp-content/upl… #gbdoc #DMOralHealth #DOC

Glad to have worked on this in one of my areas of clinical interest - a comprehensive resource for both diabetes and dentistry! Special mention to those involved esp our dentist lead Dr Rattu 🙌🏽 Have a look! GoggleDocs Prof Kamlesh Khunti EDEN Diabetes Training ABCD Diabetes 📰Diabetes Times

So proud to see Dr. Zehra Yonel from Uni of Birmingham championing the role of dental teams in diabetes screening - showing how research translates into practice. A powerful and timely message at #EuroPerio11 🇦🇹 National Institute for Health and Care Research EFP #DMOralHealth #gbdoc

New—Mexico's junk food and soda taxes thelancet.com/journals/landi… #obesity #PublicHealth #FREE to read with registration (also FREE)

👵 CGM works for older adults—but they’re being left behind 🔹 17 studies, incl. 5 RCTs: strong evidence CGM reduces hypos 🔸 HbA1c unreliable in older age—TIR & TBR matter more 🔹 CGM cuts hospitalisations, distress, & improves QoL 🔸 Yet uptake remains lowest in 65+ 👉 Age

34 year follow-up of Da Qing study 50% of Chinese adults with newly diagnosed diabetes and IGT experienced stroke. A reduced stroke risk was observed in the overall IGT intervention group diabetesjournals.org/care/article/d…

GLP1-RA therapy with liraglutide or semaglutide for 12 months is efficacious and safe for the treatment of weight regain following bariatric surgery. But what about the longer term?? link.springer.com/article/10.118…

Absolute pleasure to talk on complications and also oral health in diabetes! Spreading the knowledge … also managed to get some mentorship advice from a diabetes queen 😁 Thank you Diabetes Ireland Kate Gajewska Prof Kamlesh Khunti

🇨🇳 Mazdutide delivers in Chinese adults with obesity 🔹 Phase 3 RCT (n=610), 48 wks 🔸 Weight ↓ −14.0% (6mg), −11.0% (4mg) 🔹 50% hit ≥15% loss on 6mg vs 2% placebo 🔸 BP, lipids, liver fat & uric acid all improved 👉 Dual GLP-1/glucagon agonism is real-world ready

💦 Why taking the pee is important in MASLD too! 🔹 NHANES 2001–18: 3412 with MASLD 🔸 UACR >7.5 mg/g (even within ‘normal’) = ↑ death risk 🔹 Each 1 mg/g ↑ = +4% all-cause, +5% CV mortality 🔸 KM & spline curves confirm rising risk 👉 Check the kidneys—your liver

Interesting Commentary Liver Fibrosis testing in people with T2 Diabetes diabetesjournals.org/care/article/4… ADA Professional Publications

Screening for Undiagnosed Heart Failure Faiez ZANNAD et al sciencedirect.com/science/articl…

Our paper on second-line treatment with SGLT2i in routine practice in T2 diabetes More effective than SU or DPP4i in reducing HbA1c Effective across ages, baseline HbA1c and presence of multiple long term conditions With London School of Hygiene & Tropical Medicine & Amanda I Adler link.springer.com/article/10.100…

💉 Bimagrumab: “BELIEVE or not to BELIEVE” — that is the question Weight loss without muscle loss? 🚨 New data coming #ADA2025 🚨 👉We will be there 🧠 Most obesity drugs ↓ fat and muscle — ↑ sarcopenia risk. 🔬 Bimagrumab (ActRII blocker): ↑ lean mass, ↓ fat mass. 📊